Intuitive Surgical Inc (ISRG) stock
ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3027% above fair value
$420.95−9.58 (-2.23%)
Close on Nov 18, 2026Market cap $145.92BP/E 50.9Yield –
Intuitive Surgical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Intuitive Surgical's revenue for the twelve months ending Sep 30, 2026 was $11.58B, up 20.5% year over year. For fiscal 2025 it was $10.06B, up 20.5% from the year before. Over ten years it grew 15.5% a year on average. The highest annual figure on record is $10.06B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.06B | +20.5% |
| FY2024 | Dec 31, 2024 | $8.35B | +17.2% |
| FY2023 | Dec 31, 2023 | $7.12B | +14.5% |
| FY2022 | Dec 31, 2022 | $6.22B | +9.0% |
| FY2021 | Dec 31, 2021 | $5.71B | +31.0% |
| FY2020 | Dec 31, 2020 | $4.36B | -2.7% |
| FY2019 | Dec 31, 2019 | $4.48B | +20.3% |
| FY2018 | Dec 31, 2018 | $3.72B | +18.7% |
| FY2017 | Dec 31, 2017 | $3.14B | +16.0% |
| FY2016 | Dec 31, 2016 | $2.71B | +13.5% |
| FY2015 | Dec 31, 2015 | $2.38B | +11.9% |
| FY2014 | Dec 31, 2014 | $2.13B | -5.9% |
| FY2013 | Dec 31, 2013 | $2.27B | +4.0% |
| FY2012 | Dec 31, 2012 | $2.18B | +24.0% |
| FY2011 | Dec 31, 2011 | $1.76B | +24.4% |
| FY2010 | Dec 31, 2010 | $1.41B | +34.3% |
| FY2009 | Dec 31, 2009 | $1.05B | +20.3% |
| FY2008 | Dec 31, 2008 | $874.90M | +45.6% |
| FY2007 | Dec 31, 2007 | $600.83M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.05B | +21.7% |
| Q2 FY2026 | Jun 30, 2026 | $2.89B | +18.5% |
| Q1 FY2026 | Mar 31, 2026 | $2.77B | +23.0% |
| Q4 FY2025 | Dec 31, 2025 | $2.87B | +18.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.51B | +22.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.44B | +21.4% |
| Q1 FY2025 | Mar 31, 2025 | $2.25B | +19.2% |
| Q4 FY2024 | Dec 31, 2024 | $2.41B | +25.2% |
| Q3 FY2024 | Sep 30, 2024 | $2.04B | +16.9% |
| Q2 FY2024 | Jun 30, 2024 | $2.01B | +14.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.89B | +11.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.93B | +16.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.74B | +12.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.76B | +15.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.70B | +14.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.66B | +6.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.56B | +11.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.52B | +4.0% |
| Q1 FY2022 | Mar 31, 2022 | $1.49B | +15.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.55B | +16.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.40B | +30.2% |
| Q2 FY2021 | Jun 30, 2021 | $1.46B | +71.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.29B | +17.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.33B | +4.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.08B | -4.5% |
| Q2 FY2020 | Jun 30, 2020 | $852.10M | -22.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.10B | +12.9% |
| Q4 FY2019 | Dec 31, 2019 | $1.28B | +22.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.13B | +22.5% |
| Q2 FY2019 | Jun 30, 2019 | $1.10B | +20.9% |
| Q1 FY2019 | Mar 31, 2019 | $973.70M | +14.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.05B | +17.3% |
| Q3 FY2018 | Sep 30, 2018 | $920.90M | +14.0% |
| Q2 FY2018 | Jun 30, 2018 | $909.30M | +19.8% |
| Q1 FY2018 | Mar 31, 2018 | $847.50M | +24.7% |
| Q4 FY2017 | Dec 31, 2017 | $892.00M | +17.8% |
| Q3 FY2017 | Sep 30, 2017 | $807.80M | – |
| Q2 FY2017 | Jun 30, 2017 | $758.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $679.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $756.90M | – |
See a number that looks wrong?